Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 729

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 729
---
='center'>P.O. Box 10904

Yakima, WA 98909

Toll-Free: 877 870-8565

Collect: (206) 870-8565

Email: ksmith@advantageproxy.com</div>

If you are a shareholder of Denali and would like to request documents, please do so by , , in order to receive them before the Meeting. If you request any documents from us, we will mail them to you by first class mail, or another equally prompt means.

Information and statements contained in this proxy statement/prospectus are qualified in all respects by reference to the copy of the relevant contract or other document included as an annex to this proxy statement/prospectus.

All information contained in this proxy statement/prospectus relating to Denali has been supplied by Denali, and all such information relating to Semnur has been supplied by Semnur. Information provided by either Denali or Semnur does not constitute any representation, estimate or projection of any other party.

Neither Denali nor Semnur has authorized anyone to give any information or make any representation about the Business Combination or their respective companies that is different from, or in addition to, that contained in this proxy statement/prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. The information contained in this proxy statement/prospectus speaks only as of the date of this proxy statement/prospectus unless the information specifically indicates that another date applies.

<div align='center'>455</div>

INDEX TO FINANCIAL STATEM ENTS DENALI CAPITAL ACQUISITION CORP.

|                                                                                                                |     | Page |      |
| FINANCIAL STATEMENTS:                                                                                          |     |      |      |
| Report of Independent Registered Public Accounting Firm Marcum Asia CPAs LLP (PCAOB ID Number 5395)            |     |      | F-2  |
| Report of Independent Registered Public Accounting Firm Marcum LLP (PCAOB ID Number 688)                       |     |      | F-4  |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                   |     |      | F-6  |
| Consolidated Statements of Operations for the years ended December 31, 2024 and 2023                           |     |      | F-7  |
| Consolidated Statements of Changes in Shareholders’ Deficit for the years ended December 31,